Auriga, the brokerage firm, has recently increased the rating on Myriad Genetics (MYGN). They upped the rating from Hold to Buy. The brokerage firm believes the company may be on the upswing and there could be potential value in buying the stock. The target price is currently set at $24 per share by the brokerage firm. Shares of MYGN traded higher by 0.55% or $0.1/share to $18.30. In the past year, the shares have traded as low as $15.80 and as high as $25.89. On average, 840768 shares of MYGN exchange hands on a given day and today's volume is recorded at 466733.
Given Imaging (GIVN) recently had their rating changed from Hold to Buy. Maxim Group is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bullish sign for the company's share price, as these brokerages begin to tell their clients to start buying the upgraded stock. The shares may see a continued uptrend because of this. Analysts believe that the company's share price may begin to improve. The target price is currently set at $21 per share by the brokerage firm. Shares of GIVN traded higher by 1.4% or $0.2/share to $14.45. In the past year, the shares have traded as low as $14.09 and as high as $22.92. On average, 75069 shares of GIVN exchange hands on a given day and today's volume is recorded at 86458.
BMO Capital Markets, the brokerage firm, has recently decreased the rating on Suncor Energy (SU). They lowered the rating from Outperform to Market Perform. The brokerage firm believes the company is on the downswing and there could be potential savings or capital preservation in selling the stock now. Shares of SU fell by 3.75% or $-1.11/share to $28.47. In the past year, the shares have traded as low as $29.00 and as high as $48.53. On average, 7214590 shares of SU exchange hands on a given day and today's volume is recorded at 6820525.
BMO Capital Markets, the brokerage firm, has recently decreased the rating on Canadian Natrl Res (CNQ). They lowered the rating from Outperform to Market Perform. The brokerage firm believes the company is on the downswing and there could be potential savings or capital preservation in selling the stock now. The target price is currently set at $40 per share by the brokerage firm. Shares of CNQ fell by 2.77% or $-0.95/share to $33.40. In the past year, the shares have traded as low as $31.87 and as high as $52.04. On average, 3713450 shares of CNQ exchange hands on a given day and today's volume is recorded at 2861538.
EnCana (ECA) is currently being analyzed by the brokerage firm BMO Capital Markets. They have just increased their rating from Market Perform to Outperform. This indicates that the company may doing doing better than investors expect. Look for potential buying pressure or an upside move in the share price. The target price is currently set at $31 per share by the brokerage firm. Shares of ECA fell by 1.53% or $-0.35/share to $22.54. In the past year, the shares have traded as low as $22.71 and as high as $35.22. On average, 4708900 shares of ECA exchange hands on a given day and today's volume is recorded at 3382442.
